Home / Knowledge Centre /

Accelerating Genomic Biomarker Translation

Cancer patients’ need innovative medicines more than ever, and they require personalised therapies specific to their unique biology fast. Together, international partners such as Illumina and Almac can get pharmaceutical pipelines ready quickly for global oncology clinical trials.

Utilising comprehensive genomic panels that can test for multiple biomarkers at the same time, whilst maximising clinical trial data from one patient sample, is key to delivering these solutions at speed.

Illumina discuss how they can gain speed in clinical development by avoiding bridging studies while Almac demonstrate how we deliver diagnostic testing utilising cutting edge genomic panels & providing tailored support at clinical sites through our global footprint of CLIA and CAP certified laboratories.

Webinar presenters:


Matt Nelson

Senior Director, Companion Diagnostic (CDx) Partnering, Illumina





Dr Leeona Galligan

VP of UK Operations, Almac



Shared with kind permission from Illumina

View Resource
Almac Logo

Diagnostic Services

Your global partner for biomarker discovery, development & commercialisation.

Genomic Services

We offer a range of genomics platform and chemistry options, alongside expert data sciences support and a full sample management service.

Clinical Trial Assays

Comprehensive development, validation & delivery service for research and clinical use assays from our global clinical laboratories in USA, Europe and APAC.

Companion Diagnostics

A collaborative Companion Diagnostic partnership approach with a deep understanding of client needs. We offer CDx development, manufacture & commercialisation services.

Learn More

Please complete this form to view the Webinar

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies